Ruxolitinib improves symptoms in patients with disabling pansclerotic morphea
1. In this case series, ruxolitinib was associated with improved inflammatory markers in patients with disabling pansclerotic morphea (DPM). 2. ...
Tag: immunology
#VisualAbstract: Bariatric metabolic surgery more effective than medical therapy and lifestyle modifications for non-alcoholic steatohepatitis
1. In this randomized controlled trial, there was a significant reduction in the Disease Activity Score of rheumatoid arthritis patients ...
#VisualAbstract: Peresolimab reduces disease severity in adults with rheumatoid arthritis
1. In this randomized controlled trial, there was a significant reduction in the Disease Activity Score of rheumatoid arthritis patients ...
Epicutaneous immunotherapy is effective at desensitizing toddlers to peanut allergens
1. In this randomized controlled trial, an epicutaneous patch containing peanut protein was more effective than a placebo in raising ...
Peresolimab reduces disease severity in adults with rheumatoid arthritis
1. In this randomized controlled trial, there was a significant reduction in the Disease Activity Score of rheumatoid arthritis patients ...
Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
1. In two phase three trials, 16 weeks of lebrikizumab treatment effectively treated adolescents and adults with moderate-to-severe atopic dermatitis. ...
Pegylated interferon lambda reduces the risk of COVID-19-related hospitalization
1. In this randomized control trial, pegylated interferon lambda reduced the risk of coronavirus disease 2019 (COVID-19)-related hospitalization as compared ...
COVID-19 mRNA vaccines are safe and effective in children aged 5 to 11 years
1. In a systematic review and meta-analysis of randomized trials and cohort studies in children 5 to 11 years old, ...
Low-dose interleukin 2 may be beneficial for primary Sjögren syndrome
1. Among patients with primary Sjögren syndrome, therapy with low-dose interleukin 2 significantly improved outcomes as determined by the European ...
Self-administered subcutaneous immunoglobulin as an cost-effective alternative to clinic administration
1. Self-administered subcutaneous immunoglobulin therapy in the treatment of immunodeficiencies is significantly less costly compared to clinic-administered intravenous immunoglobulin therapy. ...
